Arrowhead Pharmaceuticals
ARWR
#2153
Rank
HK$69.94 B
Marketcap
HK$503.35
Share price
-0.68%
Change (1 day)
241.87%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) Fails to deliver data

Key failure to deliver metrics for Arrowhead Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Arrowhead Pharmaceuticals (ARWR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Arrowhead Pharmaceuticals (ARWR) - since 2016

Volume in USD (price x number of shares), data since 2016

Arrowhead Pharmaceuticals (ARWR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025HK$7.44 M-23.99%
2024HK$9.79 M55.71%
2023HK$6.28 M39.55%
2022HK$4.5 M-73.07%
2021HK$16.73 M-49.26%
2020HK$32.99 M-52.98%
2019HK$70.16 M188.2%
2018HK$24.34 M233.16%
2017HK$7.3 M-4.53%
2016HK$7.65 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Alnylam Pharmaceuticals
ALNY
HK$9.04 MHK$42.05 M๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
HK$2.5 MHK$9.09 M๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
HK$4.64 MHK$10.24 M๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$55.75 MHK$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
HK$18.93 MHK$61.71 M๐Ÿ‡บ๐Ÿ‡ธ USA